Robert T. F.

Robert T. F. is an accomplished biopharmaceutical leader with extensive experience in neuroscience and drug discovery. Currently serving as the Founder and CEO/CSO of BrainStorm Therapeutics, Inc. since March 2023, Robert focuses on developing breakthrough medicines for central nervous system disorders using innovative drug discovery methods. Previously, as Chief Scientific Officer at Vyant Bio, Robert spearheaded a significant transition towards a drug discovery platform, advancing a clinical candidate for Rett syndrome to a Phase 2 trial. Robert's notable roles also include Executive Director at CAMP4 Therapeutics, Vice President of Research and Development at AegisCN LLC, and Chief Scientific Officer at Rapid Pharma/Resolute Bio, Inc. Additionally, Robert has held significant academic positions at the University of California, San Francisco, and Duke University Medical Center, contributing to essential discoveries in neurotransmitter systems. Robert holds a PhD in Biochemistry from The George Washington University and completed postdoctoral training in Molecular Neuroscience at Columbia University.